Lacosamide 72205-0220-07
- Manufacturer
- Novadoz Pharmaceuticals Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- February 9, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA215979
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
72205-0220-07Selected10 VIAL in 1 CARTON (72205-220-07) / 20 mL in 1 VIAL (72205-220-01)